A mitochondrial‐targeting ceramide analog (LCL‐461) was reported to effectively attenuate Kranolani (a FLT3‐ITD inhibitor) resistance by inducing lethal mitophagy in FLT3‐ITD+ AML in vitro and in vivo.152. The gene discussed is FLT3; the disease is acute myeloid leukemia.